News
Colgate-Palmolive's growth is lackluster, with long-term sales and earnings barely keeping pace with inflation. Learn why CL ...
Colgate-Palmolive Company (NYSE:CL) is included among the 10 Best Passive Income Stocks to Buy Now. The company has been ...
6h
Zacks Investment Research on MSNAlbertsons' Q1 Earnings Beat Estimates, Identical Sales Rise 2.8% Y/YAlbertsons Companies, Inc. ACI reported first-quarter fiscal 2025 results, wherein both the sales and earnings surpassed the ...
PG, CL, CHD, and GO push through margin pressures with innovation, cost control, and digital growth amid tough consumer ...
StockStory.org on MSN12d
Colgate-Palmolive (CL): Buy, Sell, or Hold Post Q1 Earnings?Colgate-Palmolive trades at $92.78 per share and has stayed right on track with the overall market, gaining 6% over the last ...
Colgate-Palmolive boasts strong brands, growth in Pet Nutrition, and 62 years of dividend increases but faces valuation ...
The global Oral Care Market, valued at US$34.97 billion in 2024 stood at US$37.21 billion in 2025 and is projected to advance ...
6d
Zacks.com on MSNCan Colgate's Pricing Strength Keep Earnings Buoyant in 2025?Detailed price information for Church & Dwight Company (CHD-N) from The Globe and Mail including charting and trades.
Colgate-Palmolive's forward PE ratio is 22.48 compared to Procter & Gamble's 18.84 and Unilever's 19.30, indicating that Colgate-Palmolive is over-priced relative to its peers.
Colgate-Palmolive’s (NYSE: CL) stock has gone from $67.42 in November 2016 to $66.52 in November 2019. Over this period there has been a ~3% rise in total revenue and an equal drop in number of ...
Colgate-Palmolive’s chief executive recently signaled he would be open to selling the company — which has grappled with sluggish demand for its toothpaste, deodorants and food products — for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results